Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support

Journal of General Internal Medicine

Volumn 30, Issue 8, 2015, Pages 1133-1139

  Shelton, Jeremy B ^a,b   Ochotorena, Lee ^a   Bennett, Carol ^a,b   Shekelle, Paul ^a   Kwan, Lorna ^b   Skolarus, Ted ^c,d   Goldzweig, Caroline ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

applied informatics; cancer screening; electronic health records; implementation research; physician decision support; quality improvement

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; DECISION SUPPORT SYSTEM; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROSTATE CANCER; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; VETERANS HEALTH; BLOOD; CLINICAL DECISION SUPPORT SYSTEM; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; PROTOCOL COMPLIANCE; STANDARDS; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT; UNNECESSARY PROCEDURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DECISION SUPPORT SYSTEMS, CLINICAL; GUIDELINE ADHERENCE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY IMPROVEMENT; UNNECESSARY PROCEDURES; VETERANS HEALTH;

EID: 84938216980     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3249-y     Document Type: Article

References (35)

1. Daskivich T, et al. Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med. 2010;170(15):1396–1397.
2. USPSTF (US Preventive Services Task Force). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(3):185–191.
3. Greene KL, et al. Prostate Specific Antigen Best Practice Statement: 2009 Update. J Urol. 2009;182(5):2232–2241.
4. National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Guidelines in Oncology: Prostate Cancer Early Detection V1.2012. 2012 [cited 2015 February 9th]; Available from: http://www.nccn.org/about/permissions/request_form.asp.
5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection V1.2014 2014 [cited 2015 February 9th]; Available from: http://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf.
6. American Urological Association. EARLY DETECTION OF PROSTATE CANCER GUIDELINE. 2013 [cited 2015 February, 9th]; Available from: http://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm.
7. Prasad SM, et al. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA. 2012;307(16):1692–1694.
8. Walter LC, et al. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336–2342.
9. Walter LC, et al. Five-year downstream outcomes following prostate-specific antigen screening in older men. JAMA Intern Med. 2013;173(10):866–873.
10. VHA Office of Healthcare Transformation. VHA T21 Implementation Guidance: FY2012, 2012: VHA Intranet.
11. McGlynn EA, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–2645.
12. Ryoo JJ, Malin JL. Reconsidering the Veterans Health Administration: A Model and a Moment for Publicly Funded Health Care Delivery. Ann Intern Med. 2011;154(11):772–773.
13. Rubenstein LV, et al. A Patient-Centered Primary Care Practice Approach Using Evidence-Based Quality Improvement: Rationale, Methods, and Early Assessment of Implementation. J Gen Intern Med. 2014;29:S589–S597.
14. Yano EM, et al. Patient Aligned Care Teams (PACT): VA’s Journey to Implement Patient-Centered Medical Homes. J Gen Intern Med. 2014;29:S547–S549.
15. USPSTF (US Preventive Services Task Force). Screening for Prostate Cancer. 2012 May, 2012 [cited 2015 February 9th]; Available from: http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/prostate-cancer-screening?ds=1&s=prostate.
16. Andriole GL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–1319.
17. Schröder FH, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–1328.
18. Wright A, et al. A Description and Functional Taxonomy of Rule-based Decision Support Content at a Large Integrated Delivery Network. J Am Med Inform Assoc. 2007;14(4):489–496.
19. Hoffmann TC, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
20. Brook RH. The role of physicians in controlling medical care costs and reducing waste. JAMA. 2011;306(6):650–651.
21. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801–1802.
22. Goldzweig CL, et al. Costs and benefits of health information technology: new trends from the literature. Health Aff (Millwood). 2009;28(2):w282–w293.
23. Buntin MB, et al. The benefits of health information technology: a review of the recent literature shows predominantly positive results. Health Aff (Millwood). 2011;30(3):464–471.
24. Shojania KG, et al. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev. 2009;3, CD001096.
25. van der Sijs H, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–147.
26. Kesselheim AS, et al. Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation. Health Aff (Millwood). 2011;30(12):2310–2317.
27. Spina JR, et al. Clinical relevance of automated drug alerts from the perspective of medical providers. Am J Med Qual. 2005;20(1):7–14.
28. Eppenga WL, et al. Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in the Netherlands. J Am Med Inform Assoc. 2012;19(1):66–71.
29. Woods AD, et al. Clinical decision support for atypical orders: detection and warning of atypical medication orders submitted to a computerized provider order entry system. J Am Med Inform Assoc. 2013;21:569–573.
30. Russ AL, et al. A human factors investigation of medication alerts: barriers to prescriber decision-making and clinical workflow. AMIA Annu Symp Proc. 2009;2009:548–552.
31. Harinstein LM, et al. Use of an abnormal laboratory value-drug combination alert to detect drug-induced thrombocytopenia in critically Ill patients. J Crit Care. 2012;27(3):242–249.
32. Shah NR, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006;13(1):5–11.
33. Starmer JM, Talbert DA, Miller RA. Experience using a programmable rules engine to implement a complex medical protocol during order entry. Proc AMIA Symp. 2000:829–32.
34. Brouwers MC, et al. The landscape of knowledge translation interventions in cancer control: what do we know and where to next? A review of systematic reviews. Implement Sci. 2011;6:130.
35. Rothschild JM, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007;47(2):228–239.